The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Forecasted Rise In Market Size Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market During The Forecast Period?
The gastrointestinal over-the-counter (otc) drugs market size has experienced significant growth in recent years. Projections indicate it will expand from $49.59 billion in 2025 to $53.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.4%. This historical growth is primarily attributable to factors such as the widespread occurrence of digestive disorders, enhanced accessibility of OTC drugs, the expansion of pharmacy retail networks, evolving urban lifestyles, and shifts in dietary habits.
The gastrointestinal over-the-counter (otc) drugs market size is projected to experience robust expansion over the coming years. It will grow to $73.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth during the forecast period is driven by factors such as the increasing adoption of preventive digestive care, the expansion of e-commerce, a rising demand for clean-label OTC products, the growing aging population, and heightened awareness regarding digestive health. Key trends expected during this period involve an increase in self-medication for digestive issues, a heightened need for fast-acting OTC solutions, greater utilization of combined gastrointestinal products, a surge in online pharmacy sales, and an evolving preference for products based on herbal and enzyme formulations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
Which Significant Factors Are Encouraging Growth In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
The increasing occurrence of digestive disorders is projected to drive the expansion of the gastrointestinal OTC drugs market. Digestive disorders encompass a variety of conditions impacting the gastrointestinal tract, including the stomach, intestines, and associated organs. The rise in these disorders primarily stems from a higher intake of processed, low-fiber foods, which compromise gut health and hinder digestion. Gastrointestinal OTC drugs work by alleviating digestive disorder symptoms through the reduction of stomach acid, regulation of bowel movements, and enhancement of gut health, offering quick and accessible relief from common issues such as acidity, constipation, and indigestion. For example, in December 2023, the IBD Registry Ltd., a UK-based non-profit organization, reported that the count of individuals with inflammatory bowel disease (IBD) exceeded 5,300, representing an increase of over 3,000 members compared to 2022. Thus, the growing prevalence of digestive disorders is a significant factor propelling the growth of the gastrointestinal OTC drugs market.
How Does Segment Analysis Break Down The Gastrointestinal Over-The-Counter (OTC) Drugs Market Structure?
The gastrointestinal over-the-counter (otc) drugs market covered in this report is segmented –
1) By Product: Antacid, Laxatives, Anti-Diarrheal, Anti-Emetics, Other Products
2) By Formulation: Tablets, Capsules, Liquids, Other Formulations
3) By Indications: Heartburn, Diarrhoea, Constipation, Gastroesophageal Reflux Disease (GERD), Nausea, Vomiting, Motion Sickness, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Clinics, Home Healthcare, Other End-Users
Subsegments:
1) By Antacid: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Calcium Carbonate, Magnesium Hydroxide, Sodium Bicarbonate, Combination Antacids
2) By Laxatives: Bulk-Forming Laxatives, Stimulant Laxatives, Osmotic Laxatives, Stool Softeners, Lubricant Laxatives
3) By Anti-Diarrheal: Loperamide, Bismuth Subsalicylate, Probiotics, Electrolyte Solutions
4) By Anti-Emetics: Antihistamines, Bismuth Subsalicylate, Phosphorated Carbohydrate Solution, Ginger Supplements
5) By Other Products: Digestive Enzymes, Simethicone, Herbal Remedies, Activated Charcoal
What Trends Are Affecting The Growth Of The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Major companies operating in the gastrointestinal OTC drugs market are concentrating on developing advanced products, such as OTC proton pump inhibitors, to deliver effective and long-lasting relief from acid-related disorders. Over-the-counter (OTC) proton pump inhibitors (PPIs) are a class of non-prescription medications that reduce stomach acid production, commonly used to treat conditions like frequent heartburn, acid reflux (GERD), and gastric ulcers. For instance, in March 2025, Eisai Co., Ltd., a Japan-based pharmaceutical company, received approval in Japan to switch its Pariet S (rabeprazole sodium 10 mg) from prescription (RX) to over-the-counter (OTC) status, making it the first OTC PPI in Japan containing the same active ingredient and dosage as the prescription product. Pariet S is indicated for stomach pain, heartburn, and bloating, offering 24-hour relief with a once-daily, easy-to-swallow tablet, and aims to address the growing need for effective gastric acid-related treatments due to lifestyle and demographic changes.
Who Are The Key Market Participants In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
Major companies operating in the gastrointestinal over-the-counter (otc) drugs market are Pfizer Inc., Procter & Gamble Co., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Boehringer Ingelheim GmbH, Haleon plc, Sandoz AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd.
Access The Complete Gastrointestinal Over-The-Counter (OTC) Drugs Market Report:
What Is The Largest Regional Market In The Gastrointestinal Over-The-Counter (OTC) Drugs Market?
North America was the largest region in the gastrointestinal over-the-counter (OTC) drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal over-the-counter (otc) drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Gastrointestinal Over-The-Counter (OTC) Drugs Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24547&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Over-The-Counter (OTC) Drugs Market 2026, By The Business Research Company
Colorectal Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Otc Drug And Dietary Supplement Market Report 2026
Gastroparesis Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastroparesis-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model